Clinical and serological findings of 16 patients with systemic lupus erythematosus (SLE) who had progressive cystic bone lesions were compared with a control group of 19 patients with SLE without radiological evidence of bone cysts. Central nervous system manifestations, synovitis, and other radiologically observed skeletal abnormalities were more prevalent in the patients with cysts than in the control group. Higher concentrations of C reactive protein, and a greater incidence of rheumatoid factor positivity were seen in the patients with cysts than in the control patients, but no other serological differences were found. It is suggested that patients with SLE with progressive cystic lesions form a subgroup of the syndrome characterised by an increased acute phase reaction.
Systemic lupus erythematosus (SLE) is a highly variable disorder characterised by several immunological aberrations. These are serologically reflected by the presence of antinuclear antibodies, circulating immune complexes, and reduced complement concentrations. Characteristically, the acute phase response is moderate even in active SLE. [1] [2] [3] Involvement of the joints is the most common clinical manifestation of SLE, but objective signs of inflammation are often lacking. Also, skeletal abnormalities are uncommon.
Radiological changes, when present, usually consist of soft tissue swelling and periarticular osteoporosis; cartilaginous and osseous destruction is rare. 4 5 Recently, a deforming arthropathy of the hand in patients with SLE was characterised by Alarcon-Segovia et al. 6 We have observed a high prevalence of skeletal cystic lesions in patients with SLE. 7 This study was The laboratory data for the patients during the follow up period were screened and the highest values for C reactive protein and cryoglobulin determinations, the highest antinuclear antibody (determined by immunofluorescence on rat liver), anti-DNA antibody (Farr assay), and rheumatoid factor (latex, Waaler-Rose) titres, and the lowest total haemolytic complement values were recorded. C reactive protein values determined during obvious infections were excluded. All laboratory determinations were performed in the same laboratory.
Rank sums and rank correlations were calculated for the clinical findings and the laboratory values in the two groups.
Results
The cystic lesions were most commonly seen subchondrally in the heads of the second and third metacarpal bones or in the carpal bones (figure). Table 3 gives a summary of the laboratory data. The patients with bone cysts had higher C reactive protein concentrations and were more often rheumatoid factor positive than the control patients (p<OOl). There was also a correlation between the presence of synovitis and high concentrations of C reactive protein and rheumatoid factor (p<OOS).
Discussion
All the patients in this study fulfilled the revised American Rheumatism Association criteria for SLE, and there was no difference between the patients with progressive cystic bone lesions and the control patients without bone cysts in the presence of-antinuclear antibodies or anti-DNA antibodies. The patients without cysts were followed up radiologically for at least as long as the patients with cysts. The skeletal cystic lesions differed from the characteristic marginal erosions of rheumatoid arthritis. Cystic erosions have been described in mixed connective tissue disease with a distribution similar to that found in this study.9 None of the patients fulfilled the criteria for mixed connective tissue disease, however. Some of the erosions seen might have developed owing to eruption of marginal cysts, but the metatarsophalangeal joint erosions were radiologically very similar to those seen inrheumatoid arthritis. Deforming arthropathy, resembling that described by Alarcon-Segovia et al,6 was found more often in the patients with cysts than in the control patients.
We have previously speculated that the cystic lesions in SLE may be induced by vasculitis and impaired microcirculation.7 In this study we found no support for that hypothesis: cryoglobulins were equally common in the two groups and there was no difference in the concentrations of total haemolytic complement. Neither could we see any difference in the occurrence of clinical manifestations of vasculitis in the two patient groups. We have no explanation for the association between the occurrence of central nervous system lupus and the radiological findings. It may be of importance that the patients without skeletal cysts had been treated with immunosuppressive drugs more often than those with cystic lesions, even though the implications of this finding are unclear at present. There is no indication that treatment of deep venous thrombosis with heparin caused the cystic lesions.
Interestingly, the patients with cystic lesions showed objective signs of synovitis more often than the control patients. There Clinically, the patients with progressive cystic lesions differed form the subset of SLE with early deforming arthropathy.6 A common feature was the high positivity for rheumatoid factor, but the other clinical manifestations were different. Sicca symptoms were common in the patients with deforming arthropathy, whereas our patients with cysts had evidence of central nervous system lupus. We suggest that patients with SLE with progressive skeletal cystic lesions form a subset of the syndrome characterised by an increased acute phase response. This subset of SLE seems to differ from that described by Alarcon-Segovia et al. 6 The simultaneous presence of marginal erosions in the feet, also, suggests that these patients may represent an overlap syndrome between rheumatoid arthritis and SLE rather than a coexistence between the two entities.
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